Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

HER-2 expression + TMB-H

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

HER-2 amplification (129)

EGFR amplification + ERBB2 amplification (1)

EGFR exon 19 deletion + HER-2 amplification (1)

HER-2 amplification + MET amplification (1)

HER-2 amplification + PTEN deletion (1)

HER-2 exon 19 deletion (1)

MYC amplification + HER-2 amplification (1)

HER-2 amplification + CDK12 amplification (0)

YES1 amplification + HER-2 amplification (0)

HER-2 amplification (129)

EGFR amplification + ERBB2 amplification (1)

EGFR exon 19 deletion + HER-2 amplification (1)

HER-2 amplification + MET amplification (1)

HER-2 amplification + PTEN deletion (1)

HER-2 exon 19 deletion (1)

MYC amplification + HER-2 amplification (1)

HER-2 amplification + CDK12 amplification (0)

YES1 amplification + HER-2 amplification (0)

›

HER-2 expression + TMB-H	Gastric Cancer	HER-2 expression + TMB-H	Gastric Cancer	pembrolizumab + trastuzumab Sensitive: C3 – Early Trials pembrolizumab + trastuzumab Sensitive : C3	pembrolizumab + trastuzumab Sensitive: C3 – Early Trials pembrolizumab + trastuzumab Sensitive : C3
HER-2 expression + TMB-H	Gastroesophageal Junction Adenocarcinoma	HER-2 expression + TMB-H	Gastroesophageal Junction Adenocarcinoma	pembrolizumab + trastuzumab Sensitive: C3 – Early Trials pembrolizumab + trastuzumab Sensitive : C3	pembrolizumab + trastuzumab Sensitive: C3 – Early Trials pembrolizumab + trastuzumab Sensitive : C3